肿瘤消融市场规模、份额、成长分析：按技术、按治疗、按应用、按地区 - 行业预测，2024-2031 年

2022年全球肿瘤消融市场规模为14.8亿美元，将从2023年的16.8亿美元成长到2031年的16.8亿美元，预计在预测期（2024-2031年）复合年增长率为13.5%。 46.3亿美元。

癌症发生率的增加和对更安全治疗方案的需求不断增加是推动市场成长的主要因素。世界卫生组织 (WHO) 预测，到 2030 年，全球每年将诊断出 1,000 至 1,100 万新癌症病例。在低收入国家，新发癌症病例预计将增加 80% 以上，而高所得国家则增加 40%。癌症患者数量的快速增加，加上对微创和非侵入性治疗方案的强烈渴望，预计将在未来几年推动市场的大幅扩张。外科医生和患者对微创手术的偏好可能会增加对先进肿瘤消融技术的需求。这些技术具有恢復更快、提高患者舒适度和缩短手术时间的优点。与传统治疗不同，先进的消融方法通常在门诊进行，不需要住院，这可以降低整体医疗费用。消融对于小肿瘤尤其有效，其利用率与癌症检出率密切相关。然而，2020 年，市场因 COVID-19 大流行而受到重大影响，由于筛检活动减少，新诊断的癌症大幅减少。根据《Our World in Data》的研究，超过 70% 的癌症诊断发生在 50 岁以上的人群中，随着人口老化，这一数字预计还会增加。随着老龄化相关的身体机能下降增加癌症盛行率，对非侵入性切除术的需求预计将会增加。旨在提高精度、可操作性和成本效益的技术进步正在推动市场创新。冷却射频消融等新技术使用外部冷却探头来缩小病灶范围并减轻疼痛，看来将在未来的市场扩张中发挥关键作用。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析
  • 竞争公司之间的敌对关係
  • 替代品的威胁
  • 买方议价能力
  • 新进入者的威胁
  • 供应商的议价能力

主要市场考察

• 市场关键成功因素
• 价值链分析
• 主要投资机会
• 市场吸引力指数
• 生态系绘图
• 价格分析
• 专利分析
• 波特五力分析
• 贸易分析
• 供应链分析
• 监管分析
• 技术分析
• 案例研究分析

肿瘤消融市场：依技术分类

• 市场概况
• 射频消融术
• 微波消融
• 冷冻疗法
• 不可逆电穿孔消融
• 高强度聚焦超音波（HIFU）
• 其他技术

肿瘤消融市场：依治疗方式分类

• 市场概况
• 手术消融
• 腹腔镜消融术
• 经皮消融术

肿瘤消融市场：依应用分类

• 市场概况
• 肾癌
• 肝癌
• 乳癌
• 肺癌
• 摄护腺癌
• 其他癌症

肿瘤消融市场：按产品类型

• 市场概况
• 发电机
• 探头/电极
  • 射频消融术探头
  • 微波消融探头
  • 其他探头/电极

肿瘤消融市场：依最终用户分类

• 市场概况
• 医院/诊所
• 癌症护理中心
• 其他最终用户

肿瘤消融市场规模：按地区

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Medtronic plc（Ireland）
• Boston Scientific Corporation（US）
• Johnson & Johnson（Ethicon, Inc.）（US）
• AngioDynamics, Inc.（US）
• EDAP TMS SA（France）
• SonaCare Medical, LLC（US）
• Merit Medical Systems, Inc.（US）
• Misonix, Inc.（US）
• HealthTronics, Inc.（US）
• Galil Medical Ltd.（US）
• IceCure Medical Ltd.（Israel）
• Monteris Medical, Inc.（Canada）
• Hologic, Inc.（US）
• Symple Surgical Inc.（US）
• BVM Medical Limited（UK）
• Ablatherm（Esaote SpA）（Italy）
• Bioventus LLC（US）
• CEVOTEC（Germany）
• Fujifilm Holdings Corporation（Japan）
• InSightec Ltd.（Israel）
• Philips Healthcare（Netherlands）

Global Tumor Ablation Market size was valued at USD 1.48 Billion in 2022 and is poised to grow from USD 1.68 Billion in 2023 to USD 4.63 Billion by 2031, by rising at a CAGR 13.5% during the forecast period (2024-2031).

The growing incidence of cancer and the increasing demand for safer therapeutic options are major factors fueling market growth. The World Health Organization (WHO) projects that by 2030, there will be between 10 to 11 million new cancer cases diagnosed globally each year. In low-income countries, new cancer cases are expected to rise by over 80%, compared to a 40% increase in high-income nations. This surge in cancer cases, combined with the strong desire for minimally and non-invasive treatment options, is anticipated to drive significant market expansion in the coming years. The preference for minimally invasive procedures among both surgeons and patients is likely to enhance the demand for advanced tumor ablation techniques. These methods offer advantages such as quicker recovery, improved patient comfort, and shorter procedure times. Unlike traditional treatments, advanced ablation procedures are often performed on an outpatient basis, eliminating the need for hospital admission and reducing overall healthcare costs. Ablation is particularly effective for small tumors, and its utilization is closely linked to cancer detection rates. However, the market experienced a notable impact in 2020, as the COVID-19 pandemic led to a significant reduction in new cancer diagnoses due to decreased screening activities. A survey by Our World in Data highlights that over 70% of cancer diagnoses occur in individuals over 50, a number expected to rise with the aging population. As age-related decline in bodily functions increases the prevalence of cancer, the demand for non-invasive ablation procedures is expected to grow. Technological advancements aimed at improving accuracy, mobility, and cost-effectiveness are driving market innovation. Emerging techniques, such as cooled radiofrequency ablation, which uses externally chilled probes to enhance lesion size and provide pain relief, are poised to play a significant role in the market's future expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tumor Ablation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Tumor Ablation Market Segmental Analysis

The global tumor ablation market is segmented by technology, application, treatment, and region. Based on technology, the market is segmented into Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, High-intensity-focused Ultrasound (HIFU), and other ablation technologies. Based on treatment, the market is segmented into surgical ablation, laparoscopic ablation, and percutaneous ablation. Based on application, the market is segmented into kidney cancer, liver cancer, breast cancer, lung cancer, prostate cancer, and other cancers. Based on end users, the market is segmented into Hospitals & Clinics, Cancer Care Centers, and other End Users. Based on region, the market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Tumor Ablation Market

The increasing global incidence of cancer, especially lung, liver, kidney, and breast cancers, is significantly driving the growth of the tumor ablation market. Tumor ablation techniques are gaining prominence as they provide minimally invasive alternatives to traditional surgery, offering effective treatment options for localized tumors. These methods are particularly valuable for patients who may not be eligible for conventional surgical procedures. By offering less invasive treatment options, tumor ablation techniques address a critical need in the oncology field. They present a viable solution for patients with localized tumors, allowing for effective management of cancer while minimizing the risks and recovery times associated with more invasive surgical interventions.

Restraints in the Global Tumor Ablation Market

Tumor ablation procedures can be costly, particularly when advanced technologies and imaging guidance are used. The high expenses associated with specialized equipment, consumables, and skilled healthcare professionals can restrict access to these treatments, especially in resource-limited regions and developing countries. The financial burden of these procedures can limit their availability and make them less accessible to patients in areas with constrained healthcare resources. This cost factor poses a significant challenge to the widespread adoption of tumor ablation techniques across diverse healthcare settings.

Market Trends of the Global Tumor Ablation Market

The tumor ablation market is experiencing ongoing technological progress, resulting in the emergence of more sophisticated and precise ablation techniques. Innovations include the incorporation of imaging technologies for real-time guidance, the application of robotic systems to boost precision, and the introduction of novel energy sources for ablation. These advancements contribute to improved efficacy and safety in tumor ablation procedures. As technology continues to evolve, these developments are significantly enhancing the effectiveness of tumor ablation treatments. The integration of advanced imaging and robotic systems, along with new energy modalities, ensures greater accuracy and safety during procedures, thereby improving overall patient outcomes.

Table of Contents

Introduction

• Objectives of the study
• Definitions
• Market scope

Research methodology

• Information procurement
• Secondary & primary data sources
• Market size estimation
• Market assumptions & limitations

Executive summary

• Market overview outlook
• Supply demand trend analysis
• Segmental opportunity analysis

Market dynamics & outlook

• Market dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters' analysis
  • Competitive rivalry
  • Threat of substitute products
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key market insights

• Key success factors of the market
• Value chain analysis
• Top investment pockets
• Market attractive index
• Ecosystem mapping
• Pricing analysis
• Patent Analysis
• Porter's five forces analysis
• Trade analysis
• Supply chain analysis
• Regulatory analysis
• Technology analysis
• Case study analysis

Global Tumor Ablation Market by Technology

• Market overview
• Radiofrequency ablation
• Microwave ablation
• Cryoablation
• Irreversible electroporation ablation
• High-intensity-focused Ultrasound (HIFU)
• Other ablation technologies

Global tumor ablation market by Treatment

• Market overview
• Surgical ablation
• Laparoscopic ablation
• Percutaneous ablation

Global tumor ablation market by Application

• Market overview
• Kidney cancer
• Liver cancer
• Breast cancer
• Lung cancer
• Prostate cancer
• Other cancer

Global tumor ablation market by Product Type

• Market overview
• Generators
• Probes/electrodes
  • Radiofrequency Ablation Probes
  • Microwave Ablation Probes
  • Other Probes/Electrodes

Global tumor ablation market by End Use

• Market overview
• Hospitals & Clinics
• Cancer Care Centers
• Other End Users

Global tumor ablation market size by Region

• Market overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle east & Africa (MEA)
  • GCC countries
  • South Africa
  • Rest of MEA

Competitive landscape

• Top 5 player comparison
• Market positioning of key players, 2023
• Strategies adopted by key market players
• Recent activities in the market
• Key companies market share (%), 2023

Key company profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (Ethicon, Inc.) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EDAP TMS S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SonaCare Medical, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Misonix, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HealthTronics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Galil Medical Ltd. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IceCure Medical Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Monteris Medical, Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Symple Surgical Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BVM Medical Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ablatherm (Esaote S.p.A.)(Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioventus LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CEVOTEC (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InSightec Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments